Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Sponsor
Pfizer (Industry)
Overall Status
Approved for marketing
CT.gov ID
NCT00130897
Collaborator
(none)
274
76
Study Details
Study Description
Brief Summary
The primary objective of this protocol is to provide access to SU011248 treatment for patients with metastatic RCC who are ineligible for participation in ongoing SU011248 clinical studies and have the potential to derive clinical benefit from treatment with SU011248 based on the judgment of the investigator.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Detailed Description
Given that an Expanded Access study does not meet the definition of a controlled clinical investigation, and as such, is not considered an applicable drug clinical trial per NIH, Basic Results for such studies are not required to be reported. Protocol A6181037 has been identified as an Expanded Access trial, and has been registered to ClinicalTrials.gov, however Basic Results will not be posted.
Study Design
Study Type:
Expanded Access
Official Title:
A SU011248 Expanded Access Protocol For Systemic Therapy Of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible For Participation In Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
Study Start Date
:
Jul 1, 2005
Actual Primary Completion Date
:
Nov 1, 2011
Actual Study Completion Date
:
Nov 1, 2011
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- renal cell carcinoma that is not amendable to standard therapy with curative intent
Exclusion Criteria:
- current treatment in another therapeutic clinical trial
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Pfizer Investigational Site | Scottsdale | Arizona | United States | 85260 |
2 | Pfizer Investigational Site | San Francisco | California | United States | 94115-2378 |
3 | Pfizer Investigational Site | San Francisco | California | United States | 94115 |
4 | Pfizer Investigational Site | Aurora | Colorado | United States | 80040-0510 |
5 | Pfizer Investigational Site | Norwalk | Connecticut | United States | 06856 |
6 | Pfizer Investigational Site | Miami | Florida | United States | 33176 |
7 | Pfizer Investigational Site | Ocala | Florida | United States | 34474 |
8 | Pfizer Investigational Site | Tampa | Florida | United States | 33612 |
9 | Pfizer Investigational Site | Atlanta | Georgia | United States | 30309 |
10 | Pfizer Investigational Site | Maywood | Illinois | United States | 60153 |
11 | Pfizer Investigational Site | Indianapolis | Indiana | United States | 46260-2082 |
12 | Pfizer Investigational Site | Council Bluffs | Iowa | United States | 51503 |
13 | Pfizer Investigational Site | Covington | Louisiana | United States | 70433 |
14 | Pfizer Investigational Site | Gretna | Louisiana | United States | 70056 |
15 | Pfizer Investigational Site | Marrero | Louisiana | United States | 70072 |
16 | Pfizer Investigational Site | Metairie | Louisiana | United States | 70002 |
17 | Pfizer Investigational Site | Metairie | Louisiana | United States | 70006 |
18 | Pfizer Investigational Site | New Orleans | Louisiana | United States | 70115 |
19 | Pfizer Investigational Site | Baltimore | Maryland | United States | 21287 |
20 | Pfizer Investigational Site | Boston | Massachusetts | United States | 02114 |
21 | Pfizer Investigational Site | Boston | Massachusetts | United States | 02115 |
22 | Pfizer Investigational Site | Boston | Massachusetts | United States | 02215 |
23 | Pfizer Investigational Site | Detroit | Michigan | United States | 48201 |
24 | Pfizer Investigational Site | Minneapolis | Minnesota | United States | 55455 |
25 | Pfizer Investigational Site | Southaven | Mississippi | United States | 38671 |
26 | Pfizer Investigational Site | Tupelo | Mississippi | United States | 38801 |
27 | Pfizer Investigational Site | Columbia | Missouri | United States | 65201 |
28 | Pfizer Investigational Site | Columbia | Missouri | United States | 65203 |
29 | Pfizer Investigational Site | Omaha | Nebraska | United States | 68198-7680 |
30 | Pfizer Investigational Site | Bronx | New York | United States | 10466 |
31 | Pfizer Investigational Site | New York | New York | United States | 10021 |
32 | Pfizer Investigational Site | New York | New York | United States | 10022 |
33 | Pfizer Investigational Site | Durham | North Carolina | United States | 27710 |
34 | Pfizer Investigational Site | Cleveland | Ohio | United States | 44195 |
35 | Pfizer Investigational Site | Norman | Oklahoma | United States | 73071 |
36 | Pfizer Investigational Site | Oklahoma City | Oklahoma | United States | 73102 |
37 | Pfizer Investigational Site | Oklahoma City | Oklahoma | United States | 73109 |
38 | Pfizer Investigational Site | Oklahoma City | Oklahoma | United States | 73112 |
39 | Pfizer Investigational Site | Oklahoma City | Oklahoma | United States | 73120 |
40 | Pfizer Investigational Site | Tulsa | Oklahoma | United States | 74104 |
41 | Pfizer Investigational Site | Tulsa | Oklahoma | United States | 74136-1902 |
42 | Pfizer Investigational Site | Portland | Oregon | United States | 97210 |
43 | Pfizer Investigational Site | Portland | Oregon | United States | 97227 |
44 | Pfizer Investigational Site | Hershey | Pennsylvania | United States | 17033-0850 |
45 | Pfizer Investigational Site | Memphis | Tennessee | United States | 38104 |
46 | Pfizer Investigational Site | Memphis | Tennessee | United States | 38120 |
47 | Pfizer Investigational Site | Dallas | Texas | United States | 75246 |
48 | Pfizer Investigational Site | Salt Lake City | Utah | United States | 84112 |
49 | Pfizer Investigational Site | Seattle | Washington | United States | 98104 |
50 | Pfizer Investigational Site | Seattle | Washington | United States | 98109 |
51 | Pfizer Investigational Site | Seattle | Washington | United States | 98122 |
52 | Pfizer Investigational Site | Seattle | Washington | United States | 98124 |
53 | Pfizer Investigational Site | Madison | Wisconsin | United States | 53792 |
54 | Pfizer Investigational Site | Buenos Aires | Argentina | C1034ACO | |
55 | Pfizer Investigational Site | Buenos Aires | Argentina | C1426ANZ | |
56 | Pfizer Investigational Site | Buenos Aires | Argentina | C1431FWO | |
57 | Pfizer Investigational Site | Randwick | New South Wales | Australia | 2031 |
58 | Pfizer Investigational Site | St Leonards | New South Wales | Australia | 2065 |
59 | Pfizer Investigational Site | Westmead | New South Wales | Australia | 2145 |
60 | Pfizer Investigational Site | South Brisbane | Queensland | Australia | 4101 |
61 | Pfizer Investigational Site | Elizabeth Vale | South Australia | Australia | 5112 |
62 | Pfizer Investigational Site | Woodville South | South Australia | Australia | 5011 |
63 | Pfizer Investigational Site | East Melbourne | Victoria | Australia | 3002 |
64 | Pfizer Investigational Site | Heidelburg | Victoria | Australia | 3084 |
65 | Pfizer Investigational Site | Perth | Western Australia | Australia | 6000 |
66 | Pfizer Investigational Site | Innsbruck | Austria | 6020 | |
67 | Pfizer Investigational Site | Wien | Austria | 1090 | |
68 | Pfizer Investigational Site | Bruxelles | Belgium | 1000 | |
69 | Pfizer Investigational Site | Bruxelles | Belgium | 1200 | |
70 | Pfizer Investigational Site | Gent | Belgium | 9000 | |
71 | Pfizer Investigational Site | Leuven | Belgium | 3000 | |
72 | Pfizer Investigational Site | Liege | Belgium | 4000 | |
73 | Pfizer Investigational Site | Wilrijk | Belgium | 2610 | |
74 | Pfizer Investigational Site | Sarajevo | Bosnia and Herzegovina | 71000 | |
75 | Pfizer Investigational Site | Salvador | BA | Brazil | 41950-640 |
76 | Pfizer Investigational Site | Belo Horizonte | MG | Brazil | 30380-490 |
77 | Pfizer Investigational Site | Porto Alegre | Rio Grande do Sul | Brazil | 90020-090 |
78 | Pfizer Investigational Site | Rio de Janeiro | RJ | Brazil | 20230-130 |
79 | Pfizer Investigational Site | Rio de Janeiro | RJ | Brazil | 20231-050 |
80 | Pfizer Investigational Site | Porto Alegre | RS | Brazil | 90610-000 |
81 | Pfizer Investigational Site | Jau | SP | Brazil | 17210-120 |
82 | Pfizer Investigational Site | Jaú | SP | Brazil | 17210-080 |
83 | Pfizer Investigational Site | Jaú | SP | Brazil | 17210-120 |
84 | Pfizer Investigational Site | São Paulo | SP | Brazil | 01308-050 |
85 | Pfizer Investigational Site | São Paulo | SP | Brazil | 01509-900 |
86 | Pfizer Investigational Site | São Paulo | SP | Brazil | 05651-000 |
87 | Pfizer Investigational Site | Sofia | Bulgaria | 1504 | |
88 | Pfizer Investigational Site | Sofia | Bulgaria | 1756 | |
89 | Pfizer Investigational Site | Calgary | Alberta | Canada | T2N 4N2 |
90 | Pfizer Investigational Site | Edmonton | Alberta | Canada | T6G 1Z2 |
91 | Pfizer Investigational Site | Kelowna | British Columbia | Canada | V1Y 5L3 |
92 | Pfizer Investigational Site | Vancouver | British Columbia | Canada | V5Z 4E6 |
93 | Pfizer Investigational Site | Victoria | British Columbia | Canada | V8R 6V5 |
94 | Pfizer Investigational Site | Winnipeg | Manitoba | Canada | R3E 0V9 |
95 | Pfizer Investigational Site | Winnnipeg | Manitoba | Canada | R2H 2A6 |
96 | Pfizer Investigational Site | St. John's | Newfoundland and Labrador | Canada | A1B 3V6 |
97 | Pfizer Investigational Site | Halifax | Nova Scotia | Canada | B3H 1V7 |
98 | Pfizer Investigational Site | Halifax | Nova Scotia | Canada | B3H 2Y9 |
99 | Pfizer Investigational Site | London | Ontario | Canada | N6A 4L6 |
100 | Pfizer Investigational Site | Toronto | Ontario | Canada | M4N 3M5 |
101 | Pfizer Investigational Site | Toronto | Ontario | Canada | M5G 2M9 |
102 | Pfizer Investigational Site | Montreal | Quebec | Canada | H2L 4M1 |
103 | Pfizer Investigational Site | Montreal | Quebec | Canada | H3T 1E2 |
104 | Pfizer Investigational Site | Quebec | Canada | G1R 2J6 | |
105 | Pfizer Investigational Site | Santiago | RM | Chile | |
106 | Pfizer Investigational Site | Bogotá | Cundinamarca | Colombia | 0000 |
107 | Pfizer Investigational Site | Cali | Colombia | ||
108 | Pfizer Investigational Site | Rijeka | Croatia | 51000 | |
109 | Pfizer Investigational Site | Split | Croatia | 21000 | |
110 | Pfizer Investigational Site | Brno | Czech Republic | 656 53 | |
111 | Pfizer Investigational Site | Hradec Kralove | Czech Republic | 500 05 | |
112 | Pfizer Investigational Site | Praha 5 | Czech Republic | 150 06 | |
113 | Pfizer Investigational Site | Praha 8 | Czech Republic | 180 00 | |
114 | Pfizer Investigational Site | Guayaquil | Guayas | Ecuador | |
115 | Pfizer Investigational Site | Quito | Pichincha | Ecuador | |
116 | Pfizer Investigational Site | Cairo | Egypt | ||
117 | Pfizer Investigational Site | Giza | Egypt | ||
118 | Pfizer Investigational Site | Turku | Finland | 20521 | |
119 | Pfizer Investigational Site | Lyon | Cedex 08 | France | 69008 |
120 | Pfizer Investigational Site | Saint Herblain | Cedex | France | 44805 |
121 | Pfizer Investigational Site | Strasbourg | Cedex | France | 67091 |
122 | Pfizer Investigational Site | Bordeaux | France | 33000 | |
123 | Pfizer Investigational Site | Clermont Ferand | France | 63011 | |
124 | Pfizer Investigational Site | Marseille Cedex 9 | France | 13273 | |
125 | Pfizer Investigational Site | Marseille | France | 13385 | |
126 | Pfizer Investigational Site | Montpellier | France | 34298 cedex 05 | |
127 | Pfizer Investigational Site | Paris Cedex 13 | France | 75651 | |
128 | Pfizer Investigational Site | Paris | France | 75908 | |
129 | Pfizer Investigational Site | Reims | France | 51100 | |
130 | Pfizer Investigational Site | Rennes | France | 35042 | |
131 | Pfizer Investigational Site | Tours | France | 37044 | |
132 | Pfizer Investigational Site | Vandoeuvre les Nancy | France | 54511 | |
133 | Pfizer Investigational Site | Aachen | Germany | 52074 | |
134 | Pfizer Investigational Site | Berlin | Germany | 10117 | |
135 | Pfizer Investigational Site | Dresden | Germany | 01307 | |
136 | Pfizer Investigational Site | Essen | Germany | 45122 | |
137 | Pfizer Investigational Site | Frankfurt | Germany | 60590 | |
138 | Pfizer Investigational Site | Freiburg | Germany | 79106 | |
139 | Pfizer Investigational Site | Hamburg | Germany | 20246 | |
140 | Pfizer Investigational Site | Hannover | Germany | 30625 | |
141 | Pfizer Investigational Site | Homburg/Saar | Germany | 66421 | |
142 | Pfizer Investigational Site | Jena | Germany | 07740 | |
143 | Pfizer Investigational Site | Kassel | Germany | 34125 | |
144 | Pfizer Investigational Site | Muenchen | Germany | 81664 | |
145 | Pfizer Investigational Site | Nuernberg | Germany | 90419 | |
146 | Pfizer Investigational Site | Rostock | Germany | 18057 | |
147 | Pfizer Investigational Site | Ulm | Germany | 89081 | |
148 | Pfizer Investigational Site | Athens | Attiki | Greece | 115 22 |
149 | Pfizer Investigational Site | Athens | Greece | 11528 | |
150 | Pfizer Investigational Site | Patras | Greece | 26500 | |
151 | Pfizer Investigational Site | Thessaloniki | Greece | 540 07 | |
152 | Pfizer Investigational Site | Hong Hong | Hong Kong | ||
153 | Pfizer Investigational Site | Budapest | Hungary | 1122 | |
154 | Pfizer Investigational Site | New Delhi | Delhi | India | 110 029 |
155 | Pfizer Investigational Site | Pune | Maharashtra | India | 411 004 |
156 | Pfizer Investigational Site | Parel | Mumbai | India | 400 012 |
157 | Pfizer Investigational Site | Jaipur | Rajasthan | India | 302 004 |
158 | Pfizer Investigational Site | New Delhi | India | 110 085 | |
159 | Pfizer Investigational Site | Dublin 24 | Ireland | ||
160 | Pfizer Investigational Site | Dublin | Ireland | ||
161 | Pfizer Investigational Site | Jerusalem | Israel | ||
162 | Pfizer Investigational Site | Tel Hashomer | Israel | 52621 | |
163 | Pfizer Investigational Site | Bergamo | Italy | 24128 | |
164 | Pfizer Investigational Site | Brescia | Italy | 25123 | |
165 | Pfizer Investigational Site | Cattolica (RN) | Italy | 47841 | |
166 | Pfizer Investigational Site | Cuneo | Italy | 12100 | |
167 | Pfizer Investigational Site | Legnago, VR | Italy | 37045 | |
168 | Pfizer Investigational Site | Modena | Italy | 41100 | |
169 | Pfizer Investigational Site | Napoli | Italy | 80131 | |
170 | Pfizer Investigational Site | Padova | Italy | 35128 | |
171 | Pfizer Investigational Site | Parma | Italy | 43100 | |
172 | Pfizer Investigational Site | Pavia | Italy | 27100 | |
173 | Pfizer Investigational Site | Perugia | Italy | 06132 | |
174 | Pfizer Investigational Site | Pordenone | Italy | 33170 | |
175 | Pfizer Investigational Site | Rimini | Italy | 47900 | |
176 | Pfizer Investigational Site | Roma | Italy | 00135 | |
177 | Pfizer Investigational Site | Roma | Italy | 00144 | |
178 | Pfizer Investigational Site | Roma | Italy | 00152 | |
179 | Pfizer Investigational Site | Torino | Italy | 10126 | |
180 | Pfizer Investigational Site | Seoul | Korea, Republic of | 110-744 | |
181 | Pfizer Investigational Site | Seoul | Korea, Republic of | 120-753 | |
182 | Pfizer Investigational Site | Beirut | Lebanon | ||
183 | Pfizer Investigational Site | Petaling Jaya | Selangor | Malaysia | 46050 |
184 | Pfizer Investigational Site | Kuala Lumpur | Malaysia | 59100 | |
185 | Pfizer Investigational Site | Mexico | DF | Mexico | 06720 |
186 | Pfizer Investigational Site | Mexico | DF | Mexico | 14000 |
187 | Pfizer Investigational Site | Toluca | Estado de Mexico | Mexico | 50180 |
188 | Pfizer Investigational Site | Guadalajara | Jalisco | Mexico | 44240 |
189 | Pfizer Investigational Site | Merida | Yucatan | Mexico | 97000 |
190 | Pfizer Investigational Site | Chihuahua | Mexico | 31000 | |
191 | Pfizer Investigational Site | Puebla | Mexico | 72530 | |
192 | Pfizer Investigational Site | Groningen | GR | Netherlands | 9713 GZ |
193 | Pfizer Investigational Site | Amsterdam | NH | Netherlands | 1066 CX |
194 | Pfizer Investigational Site | Amsterdam | Netherlands | 1081 HV | |
195 | Pfizer Investigational Site | Rotterdam | Netherlands | 3075 EA | |
196 | Pfizer Investigational Site | Oslo | Norway | 0310 | |
197 | Pfizer Investigational Site | Ciudad de Panama | Panama | ||
198 | Pfizer Investigational Site | Panama | Panama | ||
199 | Pfizer Investigational Site | Lima | Peru | 11 | |
200 | Pfizer Investigational Site | Lima | Peru | L13 | |
201 | Pfizer Investigational Site | Quezon City | Philippines | 1102 | |
202 | Pfizer Investigational Site | Quezon City | Philippines | ||
203 | Pfizer Investigational Site | Gdansk | Poland | 80-210 | |
204 | Pfizer Investigational Site | Lodz | Poland | 93-509 | |
205 | Pfizer Investigational Site | Poznan | Poland | 60-569 | |
206 | Pfizer Investigational Site | Warszawa | Poland | 00-909 | |
207 | Pfizer Investigational Site | Wroclaw | Poland | 50-556 | |
208 | Pfizer Investigational Site | Lisboa | Portugal | 1070-213 | |
209 | Pfizer Investigational Site | Porto | Portugal | 4200-319 | |
210 | Pfizer Investigational Site | Bucuresti | Romania | 022328 | |
211 | Pfizer Investigational Site | Cluj-Napoca | Romania | 400015 | |
212 | Pfizer Investigational Site | Obninsk | Kaluga region | Russian Federation | 249036 |
213 | Pfizer Investigational Site | Chelyabinsk | Russian Federation | 454087 | |
214 | Pfizer Investigational Site | Moscow | Russian Federation | 115478 | |
215 | Pfizer Investigational Site | Belgrade | Serbia | 11000 | |
216 | Pfizer Investigational Site | Singapore | Singapore | 169610 | |
217 | Pfizer Investigational Site | Bratislava | Slovakia | 83301 | |
218 | Pfizer Investigational Site | Zilina | Slovakia | 012 07 | |
219 | Pfizer Investigational Site | Ljubljana | Slovenia | 1000 Ljubljana | |
220 | Pfizer Investigational Site | Oviedo | Asturias | Spain | 33006 |
221 | Pfizer Investigational Site | L'hospitalet Del Llobregat | Barcelona | Spain | 08907 |
222 | Pfizer Investigational Site | Pamplona | Navarra | Spain | 31008 |
223 | Pfizer Investigational Site | Baracaldo | Vizcaya | Spain | 48903 |
224 | Pfizer Investigational Site | Barcelona | Spain | 08025 | |
225 | Pfizer Investigational Site | Barcelona | Spain | 08035 | |
226 | Pfizer Investigational Site | La Coruña | Spain | 15006 | |
227 | Pfizer Investigational Site | Madrid | Spain | 28007 | |
228 | Pfizer Investigational Site | Madrid | Spain | 28040 | |
229 | Pfizer Investigational Site | Madrid | Spain | 28041 | |
230 | Pfizer Investigational Site | Salamanca | Spain | 37007 | |
231 | Pfizer Investigational Site | Sevilla | Spain | 41013 | |
232 | Pfizer Investigational Site | Valencia | Spain | 46009 | |
233 | Pfizer Investigational Site | Göteborg | Sweden | 413 45 | |
234 | Pfizer Investigational Site | Lund | Sweden | 221 85 | |
235 | Pfizer Investigational Site | Stockholm | Sweden | 171 76 | |
236 | Pfizer Investigational Site | Umeå | Sweden | 901 85 | |
237 | Pfizer Investigational Site | Basel | Switzerland | CH-4056 | |
238 | Pfizer Investigational Site | Bellinzona | Switzerland | CH-6500 | |
239 | Pfizer Investigational Site | Bern | Switzerland | 3010 | |
240 | Pfizer Investigational Site | Biel | Switzerland | 2500 | |
241 | Pfizer Investigational Site | CH-4058 Basel | Switzerland | ||
242 | Pfizer Investigational Site | CH-4101 Bruderholz | Switzerland | ||
243 | Pfizer Investigational Site | CH-4410 Liesthal | Switzerland | ||
244 | Pfizer Investigational Site | Chur | Switzerland | CH-7000 | |
245 | Pfizer Investigational Site | Genève 14 | Switzerland | CH-1211 | |
246 | Pfizer Investigational Site | Taipei | Taiwan | 100 | |
247 | Pfizer Investigational Site | Taipei | Taiwan | 112 | |
248 | Pfizer Investigational Site | Taoyun | Taiwan | 333 | |
249 | Pfizer Investigational Site | Bangkok | Thailand | 10330 | |
250 | Pfizer Investigational Site | Bangkok | Thailand | 10700 | |
251 | Pfizer Investigational Site | Istanbul | Capa | Turkey | 34390 |
252 | Pfizer Investigational Site | Istanbul | Cerrahpasa | Turkey | 34303 |
253 | Pfizer Investigational Site | Whitchurch | Cardiff | United Kingdom | CF14 2TL |
254 | Pfizer Investigational Site | London | Se1 9rt | United Kingdom | |
255 | Pfizer Investigational Site | Sutton | Surrey | United Kingdom | SM2 5PT |
256 | Pfizer Investigational Site | Leeds | West Yorkshire | United Kingdom | LS9 7TF |
257 | Pfizer Investigational Site | Belfast | United Kingdom | BT9 7AB | |
258 | Pfizer Investigational Site | Birmingham | United Kingdom | B15 2TH | |
259 | Pfizer Investigational Site | Birmingham | United Kingdom | B15 2TT | |
260 | Pfizer Investigational Site | Bristol | United Kingdom | BS2 8ED | |
261 | Pfizer Investigational Site | Cottingham | United Kingdom | HU16 5JQ | |
262 | Pfizer Investigational Site | Edinburgh | United Kingdom | EH4 2XU | |
263 | Pfizer Investigational Site | Guildford | United Kingdom | GU2 5XX | |
264 | Pfizer Investigational Site | London | United Kingdom | EC1A 7BE | |
265 | Pfizer Investigational Site | London | United Kingdom | NW3 2Qg | |
266 | Pfizer Investigational Site | London | United Kingdom | SW3 6JJ | |
267 | Pfizer Investigational Site | Manchester | United Kingdom | M20 4BX | |
268 | Pfizer Investigational Site | Northwood | United Kingdom | HA6 2RN | |
269 | Pfizer Investigational Site | Nottingham | United Kingdom | NG5 1PB | |
270 | Pfizer Investigational Site | Sheffield | United Kingdom | S10 2SJ | |
271 | Pfizer Investigational Site | Southampton | United Kingdom | SO16 6YD | |
272 | Pfizer Investigational Site | Swansea | United Kingdom | SA2 8QA | |
273 | Pfizer Investigational Site | Caracas | Distrito Capital | Venezuela | 1040 |
274 | Pfizer Investigational Site | Caracas | Estado Miranda | Venezuela | 1060 |
Sponsors and Collaborators
- Pfizer
Investigators
- Study Director: Pfizer CT.gov Call Center, Pfizer
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Pfizer
ClinicalTrials.gov Identifier:
NCT00130897
Other Study ID Numbers:
- A6181037
First Posted:
Aug 16, 2005
Last Update Posted:
Mar 9, 2012
Last Verified:
Mar 1, 2012